← Astrana Health, Inc. ASTH
Market Price
$40.74
Market Cap
$1.87B
P/E Ratio
88.57
Revenue (FY 2025)
↑56.4% YoY
$3.18B
3-Yr CAGR: 40.6%
Net Income
↓-47.9% YoY
$22.49M
Net Margin: 0.7%
Free Cash Flow
↑136.6% YoY
$104.49M
FCF Yield: 5.57%
EPS (Diluted)
↓-48.9% YoY
$0.46
Basic: $0.46
Return on Equity
Efficiency
2.9%
ROA: 85.6%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (ASTH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $44.0M | — | $9.7M | $-9.3M | — | $0.41 | — | $21.9M | $21.7M | — |
| FY 2017 | $357.7M | +712.2% | $61.6M | $25.8M | +376.1% | $0.90 | +119.5% | $51.9M | $49.8M | +130.2% |
| FY 2018 | $519.9M | +45.3% | $158.8M | $10.8M | -58.0% | $0.29 | -67.8% | $25.5M | $24.3M | -51.2% |
| FY 2019 | $560.6M | +7.8% | $92.8M | $14.1M | +30.3% | $0.39 | +34.5% | $13.7M | $12.6M | -48.1% |
| FY 2020 | $687.2M | +22.6% | $148.0M | $37.9M | +168.2% | $1.01 | +159.0% | $46.2M | $45.0M | +256.2% |
| FY 2021 | $773.9M | +12.6% | $177.8M | $73.9M | +95.1% | $1.63 | +61.4% | $70.3M | $51.1M | +13.6% |
| FY 2022 | $1,144.2M | +47.8% | $199.5M | $45.2M | -38.8% | $0.99 | -39.3% | $82.1M | $59.2M | +15.8% |
| FY 2023 | $1,386.7M | +21.2% | $215.0M | $60.7M | +34.4% | $1.29 | +30.3% | $68.2M | $39.7M | -32.9% |
| FY 2024 | $2,034.5M | +46.7% | $271.4M | $43.1M | -28.9% | $0.90 | -30.2% | $52.2M | $44.2M | +11.3% |
| FY 2025 | $3,181.8M | +56.4% | $341.5M | $22.5M | -47.9% | $0.46 | -48.9% | $114.6M | $104.5M | +136.6% |
Valuation
Market Price
$40.74
Market Cap
$1.87B
Enterprise Value
$2.48B
P/E Ratio
88.57
P/B Ratio
2.59
FCF Yield
5.57%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
10.73%
Operating Margin
2.47%
Net Margin
0.71%
Return on Equity (ROE)
2.89%
Return on Assets (ROA)
85.62%
Asset Turnover
121.15x
Revenue 3-Yr CAGR
40.62%
Financial Health & Liquidity
Current Ratio
0.04
Cash Ratio
0.70
Debt / Equity
1.333
Debt / Assets
39.551
Cash & Equivalents
$429.47M
Total Debt
$1.04B
Book Value / Share
$15.72
Cash Flow Efficiency
Operating Cash Flow
$114.60M
Capital Expenditures (CapEx)
$10.11M
Free Cash Flow
$104.49M
OCF / Revenue
3.60%
FCF / Revenue
3.28%
FCF 3-Yr CAGR
20.86%
Per Share Metrics
EPS (Diluted)
$0.46
EPS (Basic)
$0.46
Dividends / Share
N/A
Book Value / Share
$15.72
EPS YoY Growth
-48.89%
Balance Sheet (FY 2025)
Total Assets
$26.26M
Total Liabilities
$615.27M
Stockholders' Equity
$779.29M
Current Assets
$26.26M
Current Liabilities
$615.27M